GI-270384X

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGI-270384X
Drug Alias NameGI-270384XGI-270384
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntercellular adhesion molecule-1 inhibitorsSelectin E inhibitors
TargetsIntercellular adhesion molecule-1Selectin E
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel DiseasesColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A